Early Oral Intake Following Cesarean Surgery - Full Text View

Sponsored by:	Tehran University of Medical Sciences
Information provided by:	Tehran University of Medical Sciences
ClinicalTrials.gov Identifier:	NCT00370708

Purpose

In this study we are trying to compare the safety and financial benefit of starting the realimentation early versus conventional oral intake following the Cesarean surgery in Iran.

Condition	Intervention
Obstetrics Surgery	Procedure: Oral Intake following admittance to the postpartum ward

Study Type:	Interventional
Study Design:	Supportive Care, Randomized, Single Blind, Active Control, Single Group Assignment
Official Title:	Early Oral Intake Following Elective Cesarean Surgery in Iranian Women; the Economic Burdens and Patient Satisfaction

Resource links provided by NLM:

MedlinePlus related topics: Surgery

U.S. FDA Resources

Further study details as provided by Tehran University of Medical Sciences:

Primary Outcome Measures:

Tolerance of Oral Intake

Study Start Date:	April 2003
Estimated Study Completion Date:	February 2004

Detailed Description:

Cesarean delivery is announced to constitute 50% of deliveries in the Capital and 39% of all the deliveries nationwide, which is far beyond the acceptable international normal range, according to the official site of the Ministry of Health and Medical Education of the Islamic Republic of Iran [http://www.mohme.gov.ir/HNDC/Indicators/Simaye_Salamt/Simaye_Salamat.htm]. This high rate of elective cesarean deliveries might be due to several reasons which are far beyond the scope of this study. Here we tried to see whether the reduction in the time of hospitalization for these patients is safe at the expense of earlier oral realimentation and to see whether this strategy increases the patients' satisfaction or not.

Eligibility

Ages Eligible for Study:	20 Years to 35 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Women who had elective cesarean deliveries under regional anesthesia

Exclusion Criteria:

Receiving general anesthesia, magnesium sulfate or insulin.
Coming across an intraoperative bowel injury.
Having any medical or gastrointestinal problem that prohibits early feeding

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00370708

Locations

Iran, Islamic Republic of
Department of Obstetrics and Gynecology, Arash Hospital
Tehran, Iran, Islamic Republic of, 19986

Sponsors and Collaborators

Tehran University of Medical Sciences

Investigators

Principal Investigator:

Afsaneh Tehranian, Assist Pro

Department of Obstetrics and Gynecology, Arash Hospital, Tehran University of Medical Sciences, Tehran/Iran

More Information

No publications provided

Study ID Numbers:	1383FK
Study First Received:	August 31, 2006
Last Updated:	September 6, 2006
ClinicalTrials.gov Identifier:	NCT00370708 History of Changes
Health Authority:	Iran: Ethics Committee

Keywords provided by Tehran University of Medical Sciences:

Cesarean
Oral
Intake

ClinicalTrials.gov processed this record on September 09, 2009